NDC 68982-140 - NUWIQ
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68982-140
- Package NDCs from labels
- 68982-140-01
- Manufacturer
- Octapharma USA Inc
- Effective date
- 2024-12-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NUWIQ - Octapharma USA Inc | Octapharma USA Inc | 2024-12-26 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68982-140-01 | NUWIQ | 2.5 mL in 1 VIAL | POWDER, FOR SOLUTION | 2.5 mL | 250 [iU] in 2.5mL | 16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Water | ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO | NET Remedies | 3dc6fdf6-781c-4dec-9aab-a2237fc60c53 | 2021-01-19 | Warnings | Water |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.